Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
Viruses|November 4, 2020
HCV Genetic Diversity Can Be Used to Infer Infection Recency and Time since InfectionLouisa A Carlisle, Teja Turk, Karin J Metzner, et al.
BMC Cancer|April 16, 2024
Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cancer (mCRPC) by integrating the VTX-1 CTC isolation system with the QIAGEN AdnaTestHaiyan E Liu, Meghah Vuppalapaty, Christian R Hoerner, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
The m6A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressorYiren Xiao, Kaushik N Thakkar, Hongjuan Zhao, et al.
The Journal of Infectious Diseases|April 29, 2022
A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort StudySandra E Chaudron, Christine Leemann, Katharina Kusejko, et al.
The Journal of Infectious Diseases|July 13, 2013
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infectionKarin J Metzner, Alexandra U Scherrer, Benjamin Preiswerk, et al.
Plos One|January 13, 2016
A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep PyrosequencingElizabeth P St John, Birgitte B Simen, Gregory S Turenchalk, et al.
The Journal of Infectious Diseases|March 6, 2019
Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time Since InfectionLouisa A Carlisle, Teja Turk, Katharina Kusejko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2019
Noninferiority of Simplified Dolutegravir Monotherapy Compared to Continued Combination Antiretroviral Therapy That Was Initiated During Primary Human Immunodeficiency Virus Infection: A Randomized, Controlled, Multisite, Open-label, Noninferiority TrialDominique L Braun, Teja Turk, Fabian Tschumi, et al.
Retrovirology|September 7, 2016
Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairsCorinna S Oberle, Beda Joos, Peter Rusert, et al.
Nature Cell Biology|February 13, 2026
Sequence and chemical specificity define the functional landscape of intrinsically disordered regionsIris Langstein-Skora, Andrea Schmid, Frauke Huth, et al.
Pageof 18